Michel Burnier

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


906 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ...
In press
 
Medical Measures in Hypertensives Considered Resistant.
Fadl Elmula FEM, Mariampillai J.E., Heimark S., Kjeldsen S.E., Burnier M. American journal of hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_1F534B9B1153]
 
Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.
Mancia G., Brunström M., Burnier M., Grassi G., Januszewicz A., Kjeldsen S.E., Muiesan M.L., Thomopoulos C., Tsioufis K., Kreutz R. Hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_839A036770BB]
 
Optimizing drug adherence in hypertension: More than a mind game.
Robberechts T., Stoenoiu M.S., Burnier M., Persu A. Kardiologia polska. Peer-reviewed.
[DOI][Pmid][serval:BIB_7CE472FF2113]
 
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.
Sarafidis P., Schmieder R., Burnier M., Persu A., Januszewicz A., Halimi J.M., Arici M., Ortiz A., Wanner C., Mancia G. et al. Nephrology, dialysis, transplantation. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_375A45238359]
 
A new, deep learning-based method for the analysis of autopsy kidney samples used to study sex differences in glomerular density and size in a forensic population.
Vilmont V., Ngatchou N., Lioux G., Kalucki S., Brito W., Burnier M., Rotman S., Lardi C., Pruijm M. International journal of legal medicine. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6772A8E19616]
2024
Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?
Kjeldsen S.E., Egan B.M., Burnier M., Narkiewicz K., Kreutz R., Mancia G., 2024/12. Blood pressure, 33 (1) p. 2329571. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A45F469F2BCE]
 
Use of individual antihypertensive drug classes and combination therapies during the COVID-19 pandemic in Poland: a cross-sectional, nationwide study in the years 2019-2021.
Dobrowolski P., Prejbisz A., Bożek G., Koń B., Machnio A., Urbański F., Nowak F., Topór-Mądry R., Burnier M., Januszewicz A. et al., 2024/03/27. Polish archives of internal medicine, 134 (3) p. 16647. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9629B160A0AB]
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines.
Mancia G., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Kjeldsen S.E., Kreutz R., 2024/03. European journal of internal medicine, 121 pp. 4-8. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_12C8E07BCCBD]
The current best drug treatment for hypertensive heart failure with preserved ejection fraction.
Rist A., Sevre K., Wachtell K., Devereux R.B., Aurigemma G.P., Smiseth O.A., Kjeldsen S.E., Julius S., Pitt B., Burnier M. et al., 2024/02. European journal of internal medicine, 120 pp. 3-10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2444A51BE43E]
 
The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study.
Bandiera C., Dotta-Celio J., Locatelli I., Nobre D., Wuerzner G., Pruijm M., Lamine F., Burnier M., Zanchi A., Schneider M.P., 2024. Frontiers in pharmacology, 15 p. 1294436. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_066459A6BF3A]
The role of adherence in patients with chronic diseases.
Burnier M., 2024/01. European journal of internal medicine, 119 pp. 1-5. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_246034D5202B]
 
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence.
Sevre K., Rist A., Wachtell K., Devereux R.B., Aurigemma G.P., Smiseth O.A., Kjeldsen S.E., Julius S., Pitt B., Burnier M. et al., 2024/01/01. American journal of hypertension, 37 (1) pp. 1-14. Peer-reviewed.
[DOI][Pmid][serval:BIB_962EADA3BC8E]
2023
 
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).
Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Agabiti-Rosei E., Algharably EAE et al., 2023/12/01. Journal of hypertension, 41 (12) pp. 1874-2071. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1685ABBB3425]
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension.
Kjeldsen S.E., Egan B.M., Narkiewicz K., Kreutz R., Burnier M., Oparil S., Mancia G., 2023/12. Blood pressure, 32 (1) pp. 1-3. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F0342E2ED706]
 
Women's health, cardiovascular risk and hypertension: the perspective still needs to improve.
Burnier M., Brguljan J., Algharably EAE, Kjeldsen S.E., Narkiewicz K., Egan B., Oparil S., Kreutz R., 2023/12. Blood pressure, 32 (1) p. 2193648. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3E391CF7B9F3]
 
Diagnosis of cardiovascular disease in patients with chronic kidney disease.
Zoccali C., Mark P.B., Sarafidis P., Agarwal R., Adamczak M., Bueno de Oliveira R., Massy Z.A., Kotanko P., Ferro C.J., Wanner C. et al., 2023/11. Nature reviews. Nephrology, 19 (11) pp. 733-746. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_876F8357F955]
Blood pressure control in tertiary-care hypertensive patients during COVID-19 pandemic
Wolf Jacek, Nieckarz Anna, Panfil Anna, Białas Aleksandra, Sternicka Julia, Jędrzejewski Łukasz, Hoffmann Michał, Szyndler Anna, Prejbisz Aleksander, Burnier Michel et al., 2023/09/30. Arterial Hypertension, 27 (3) pp. 145-151.
[URN][DOI][WoS][serval:BIB_A8801E65C251]
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
Zoccali C., Mallamaci F., Adamczak M., de Oliveira R.B., Massy Z.A., Sarafidis P., Agarwal R., Mark P.B., Kotanko P., Ferro C.J. et al., 2023/09/05. Cardiovascular research, 119 (11) pp. 2017-2032. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FDDBFAFA00AA]
How to optimize the use of diuretics in patients with heart failure?
Burnier M., Narkiewicz K., Kjeldsen S.E., 2023/09. Kardiologia polska, 81 (10) pp. 944-949. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5FE1A04EE675]
 
Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension.
Mancia G., Cappuccio F.P., Burnier M., Coca A., Persu A., Borghi C., Kreutz R., Sanner B., 2023/09. Journal of internal medicine, 294 (3) pp. 251-268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D6C0EDD666B]
 
Partnership between patients and interprofessional healthcare providers along the multifaceted journey to medication adherence.
Schneider M.P., Burnier M., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 1992-1995. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_310D79A2F509]
Determinants of Renal Micro-Perfusion as Assessed with Contrast-Enhanced Ultrasound in Healthy Males and Females.
Ulpiano Trillig A., Damianaki A., Hendriks-Balk M., Brito W., Garessus J., Burnier M., Wuerzner G., Pruijm M., 2023/06/20. Journal of clinical medicine, 12 (12) p. 4141. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_36659E8E9115]
 
Variability of 24-Hour Sodium Urinary Excretion in Young Healthy Males Based on Consecutive Urine Collections: Impact on Categorization of Salt Intake.
Jaques D.A., Ponte B., Olivier V., de Seigneux S., Feraille E., Burnier M., Pechère-Bertschi A., 2023/05. Journal of renal nutrition, 33 (3) pp. 450-455. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_39314F6C786C]
 
Key questions regarding the SYMPLICITY HTN-3 trial.
Kjeldsen S.E., Burnier M., Narkiewicz K., Kreutz R., Mancia G., 2023/04/22. Lancet, 401 (10385) pp. 1336-1337. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3B116250262]
 
Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease.
Burnier M., Damianaki A., 2023/04/14. Circulation research, 132 (8) pp. 1050-1063. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F745C0868C6]
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations.
Burnier M., Redon J., Volpe M., 2023/03. High blood pressure & cardiovascular prevention, 30 (2) pp. 109-121. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E88B8BE11962]
 
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
Ortiz A., Ferro C.J., Balafa O., Burnier M., Ekart R., Halimi J.M., Kreutz R., Mark P.B., Persu A., Rossignol P. et al., 2023/01/23. Nephrology, dialysis, transplantation, 38 (1) pp. 10-25. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_536AFB717F2D]
Dietary salt and NCDs: Burden, epidemiology and priority interventions
Bovet Pascal, Burnier Michel, Banatvala Nick, Nederveen Leo, 2023/01/18. pp. 157-163 dans Banatvala Nick, Bovet Pascal (eds.) Noncommunicable Diseases: A Compendium chap. 21, Routledge.
[URN][DOI][serval:BIB_BCE49226BC36]
Hypertension: Burden, epidemiology and priority interventions
Bovet Pascal, Schutte Alta E., Banatvala Nick, Burnier Michel, 2023/01/18. pp. 58-65 dans Banatvala Nick, Bovet Pascal (eds.) Noncommunicable Diseases: A Compendium chap. 8, Routledge.
[URN][DOI][serval:BIB_AE3A67A24D23]
Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease.
Trucello L., Nobre D., Sabaratnam V., Bonny O., Wuerzner G., Burnier M., Fakhouri F., Pruijm M., Zanchi A., 2023. Frontiers in cardiovascular medicine, 10 p. 1230227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_199BBB7CA1E4]
Gout and hyperuricaemia: modifiable cardiovascular risk factors?
Burnier M., 2023. Frontiers in cardiovascular medicine, 10 p. 1190069. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C350B8F456E2]
Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension.
Schmieder R., Burnier M., East C., Tsioufis K., Delaney S., 2023. Interventional cardiology, 18 pp. e06. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E77A502C0302]
The impact of war on the development and progression of arterial hypertension and cardiovascular disease: protocol of a prospective study among Ukrainian female refugees.
Shalimova A., Stoenoiu M.S., Cubała W.J., Burnier M., Persu A., Narkiewicz K., 2023. Frontiers in cardiovascular medicine, 10 p. 1324367. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE274E13CA4E]
2022
 
A 30th anniversary and a glimpse of the future.
Burnier M., Kjeldsen S.E., 2022/12. Blood pressure, 31 (1) pp. 1-3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_153462F73BCA]
 
Accuracy of blood pressure measurement across BMI categories using the OptiBP™ mobile application.
Caillat M., Degott J., Wuerzner A., Proençain M., Bonnier G., Knebel J.F., Stoll C., Christen U., Durgnat V., Hofmann G. et al., 2022/12. Blood pressure, 31 (1) pp. 288-296. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_44BA3AFA4503]
 
High blood pressure screening in pharmacies during May Measurement Month campaigns in Switzerland.
Damianaki A., Theiler K., Beaney T., Wang W., Burnier M., Wuerzner G., 2022/12. Blood pressure, 31 (1) pp. 129-138. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46C1E149F738]
 
Hypertension management during the COVID-19 pandemic: what can we learn for the future?
Burnier M., Kjeldsen S.E., Narkiewicz K., Egan B., Kreutz R., 2022/12. Blood pressure, 31 (1) pp. 47-49. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EF3DAF2FB021]
Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure.
Narkiewicz K., Kjeldsen S.E., Egan B.M., Kreutz R., Burnier M., 2022/12. Blood pressure, 31 (1) pp. 207-209. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4E3DE4C7D03F]
 
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions.
Egan B.M., Kjeldsen S.E., Narkiewicz K., Kreutz R., Burnier M., 2022/12. Blood pressure, 31 (1) pp. 164-168. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A23838C471A5]
 
Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy.
Kjeldsen S.E., Egan B.M., Narkiewicz K., Kreutz R., Burnier M., Oparil S., 2022/12. Blood pressure, 31 (1) pp. 125-128. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A315F72BE81]
Renal denervation in the antihypertensive arsenal - knowns and known unknowns.
Messerli F.H., Bavishi C., Brguljan J., Burnier M., Dobner S., Elijovich F., Ferdinand K.C., Kjeldsen S., Laffer C.L., S Ram C.V. et al., 2022/10/01. Journal of hypertension, 40 (10) pp. 1859-1875. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B326C47342F5]
 
Defining intradialytic hypertension: the importance of measuring blood pressure accurately.
Wuerzner G., Pruijm M., Burnier M., 2022/09/22. Nephrology, dialysis, transplantation, 37 (10) pp. 1783-1785. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5065B491E932]
May Measurement Month 2017-2019: results from Switzerland<sup></sup>.
Damianaki A., Wang W., Beaney T., Burkard T., Sudano I., Burnier M., Wuerzner G., 2022/09. European heart journal supplements, 24 (Suppl F) pp. F38-F40. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30A37F3EB95A]
 
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.
Harmacek D., Pruijm M., Burnier M., Muller M.E., Ghajarzadeh-Wurzner A., Bonny O., Zanchi A., 2022/06. Journal of the American Society of Nephrology, 33 (6) pp. 1073-1075. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B566D465A0A5]
Improving the Management of Hypertension by Tackling Awareness, Adherence, and Clinical Inertia: A Symposium Report.
Pathak A., Poulter N.R., Kavanagh M., Kreutz R., Burnier M., 2022/05. American journal of cardiovascular drugs, 22 (3) pp. 251-261. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_897B7757F21C]
 
Association between post-traumatic stress disorder and hypertension in Congolese exposed to violence: a case-control study.
Bapolisi A., Maurage P., Pappaccogli M., Georges CMG, Petit G., Balola M., Cikomola C., Bisimwa G., Burnier M., Persu A. et al., 2022/04/01. Journal of hypertension, 40 (4) pp. 685-691. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CFF7B80A02EF]
 
Cortical perfusion as assessed with contrast-enhanced ultrasound is lower in patients with chronic kidney disease than in healthy subjects but increases under low salt conditions.
Garessus J., Brito W., Loncle N., Vanelli A., Hendriks-Balk M., Wuerzner G., Schneider A., Burnier M., Pruijm M., 2022/03/25. Nephrology, dialysis, transplantation, 37 (4) pp. 705-712. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AF32F83585F7]
 
Selling, buying and eating – a synthesis study on dietary patterns across language regions in Switzerland
Matthes Katarina L., Zuberbuehler Christine A., Rohrmann Sabine, Hartmann Christina, Siegrist Michael, Burnier Michel, Bochud Murielle, Zwahlen Marcel, Bender Nicole, Staub Kaspar, 2022/03/21. British Food Journal, 124 (5) pp. 1502-1518.
[DOI][WoS][serval:BIB_CCE3D3671925]
New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy.
Damianaki A., Polychronopoulou E., Wuerzner G., Burnier M., 2022/03. High blood pressure & cardiovascular prevention, 29 (2) pp. 125-135. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EFFF2E71408F]
Dietary sodium intake does not alter renal potassium handling and blood pressure in healthy young males.
Pechère-Bertschi A., Olivier V., Burnier M., Udwan K., de Seigneux S., Ponte B., Maillard M., Martin P.Y., Feraille E., 2022/02/25. Nephrology, dialysis, transplantation, 37 (3) pp. 548-557. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_81177BECC2D0]
 
Clinical benefits of hypertension management: a look to the past to strengthen the future.
Burnier M., 2022/02/19. European journal of preventive cardiology, 29 (1) pp. 167-168. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0B8CB62AC3C0]
Changes of lipoprotein(a) levels with endogenous steroid hormones.
Tessitore E., Dobretz K., Dhayat N.A., Kern I., Ponte B., Pruijm M., Ackermann D., Estoppey S., Burnier M., Martin P.Y. et al., 2022/02. European journal of clinical investigation, 52 (2) pp. e13699. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5156A7619A31]
 
Renal denervation for patients with chronic kidney disease and resistant hypertension: effective and safe but still not the panacea.
Burnier M., 2022/01/25. Nephrology, dialysis, transplantation, 37 (2) pp. 208-210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_86068DB3776E]
Prevalence and Factors Associated with Opioid Prescription in Swiss Chronic Hemodialysis Patients
Hennebel Clémence, Vilmont Valérie, Cherpillod Anne, Fumeaux David, Fakhouri Fadi, Livio Françoise, Burnier Michel, Pruijm Menno, 2022/01/02. Kidney and Dialysis, 2 (1) pp. 6-15.
[URN][DOI][serval:BIB_01CCFE785454]
 
A quantitative synthesis study on body mass index and associated factors among adult men and women in Switzerland.
Matthes K.L., Hartmann C., Siegrist M., Burnier M., Bochud M., Zwahlen M., Bender N., Staub K., 2022. Journal of nutritional science, 11 pp. e65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9EDF1F8EB24E]
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis.
Pisano A., Mallamaci F., D'Arrigo G., Bolignano D., Wuerzner G., Ortiz A., Burnier M., Kanaan N., Sarafidis P., Persu A. et al., 2022/01. Clinical kidney journal, 15 (1) pp. 31-42. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AD3E1794750]
 
Contrast-Enhanced Ultrasound and Protein Shakes Are No Alternatives for Inulin Clearance and Meat to Assess Renal Functional Reserve in Humans.
Damianaki A., Brito W., Garessus J., Schneider A., Maillard M., Burnier M., Pruijm M., 2022. Kidney & blood pressure research, 47 (11) pp. 664-673. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7822A73648DA]
COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis.
Tylicki L., Biedunkiewicz B., Puchalska-Reglińska E., Gellert R., Burnier M., Wolf J., Dȩbska-Ślizień A., 2022. Frontiers in medicine, 9 p. 937167. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3FB291B8802A]
Editorial: Insights in hypertension: 2021.
Burnier M., 2022. Frontiers in cardiovascular medicine, 9 p. 1003939. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F8FF34C63EC]
Increased glucocorticoid metabolism in diabetic kidney disease.
Ackermann D., Vogt B., Bochud M., Burnier M., Martin P.Y., Paccaud F., Ehret G., Guessous I., Ponte B., Pruijm M. et al., 2022. PloS one, 17 (6) pp. e0269920. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_435625327C21]
 
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing.
Lane D., Lawson A., Burns A., Azizi M., Burnier M., Jones DJL, Kably B., Khunti K., Kreutz R., Patel P. et al., 2022/01. Hypertension, 79 (1) pp. 12-23. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D707A5E9093]
 
Sex differences in the occurrence and reporting of adverse drug reactions in hypertension: What are the clinical implications?
Burnier M., 2022. Kardiologia polska, 80 (11) pp. 1065-1067. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AC88963183B4]
Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action.
Bandiera C., Ribaut J., Dima A.L., Allemann S.S., Molesworth K., Kalumiya K., Käser F., Olson M.S., Burnier M., van Boven JFM et al., 2022. International journal of public health, 67 p. 1605204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9A9F2371DDD2]
Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.
Zanchi A., Pruijm M., Muller M.E., Ghajarzadeh-Wurzner A., Maillard M., Dufour N., Bonny O., Wuerzner G., Burnier M., 2022. Frontiers in cardiovascular medicine, 9 p. 854230. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6281EA6B3D3F]
2021
 
Is modifying salt intake an effective treatment strategy for hypertension control?
Burnier M., 2021/12/31. Nephrology, dialysis, transplantation, 37 (1) pp. 31-32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22547EEFD8F2]
 
Global warming applied to dialysis: facts and figures.
Burnier M., Fouque D., 2021/12/02. Nephrology, dialysis, transplantation, 36 (12) pp. 2167-2169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21F8A4271CBD]
 
Assessment of a strategy combining ambulatory blood pressure, adherence monitoring and a standardised triple therapy in resistant hypertension.
Polychronopoulou E., Burnier M., Ehret G., Schoenenberger-Berzins R., Berney M., Ponte B., Erne P., Bochud M., Pechère-Bertschi A., Wuerzner G., 2021/12. Blood pressure, 30 (6) pp. 332-340. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5FFCC4F2CB0]
 
The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2021/12. Blood pressure, 30 (6) pp. 327-331. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3F2E087326D]
 
Sex differences in the progression of kidney injury and risk of death in CKD patients: is different ambulatory blood pressure control the underlying cause?
Sarafidis P., Burnier M., 2021/11/09. Nephrology, dialysis, transplantation, 36 (11) pp. 1965-1967. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_00C01A025BD6]
 
Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection.
Narkiewicz K., Burnier M., Kjeldsen S.E., Oparil S., 2021/10. Blood pressure, 30 (5) pp. 267-268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_61011F75871D]
 
Hypertension healthcare professional beliefs and behaviour regarding patient medication adherence: a survey conducted among European Society of Hypertension Centres of Excellence.
Burnier M., Prejbisz A., Weber T., Azizi M., Cunha V., Versmissen J., Gupta P., Vaclavik J., Januszewicz A., Persu A. et al., 2021/10. Blood pressure, 30 (5) pp. 282-290. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B62C977407F9]
Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension.
Parati G., Stergiou G.S., Bilo G., Kollias A., Pengo M., Ochoa J.E., Agarwal R., Asayama K., Asmar R., Burnier M. et al., 2021/09/01. Journal of hypertension, 39 (9) pp. 1742-1767. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F8281E94CB13]
 
Cuff-less measurements of blood pressure: are we ready for a change?
Burnier M., Kjeldsen S.E., Narkiewicz K., Oparil S., 2021/08. Blood pressure, 30 (4) pp. 205-207. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_54DC61DF0E6B]
 
Hypertension in kidney transplantation: a consensus statement of the 'hypertension and the kidney' working group of the European Society of Hypertension.
Halimi J.M., Ortiz A., Sarafidis P.A., Mallamaci F., Wuerzner G., Pisano A., London G., Persu A., Rossignol P., Sautenet B. et al., 2021/08/01. Journal of hypertension, 39 (8) pp. 1513-1521. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_359B2536C5C6]
 
Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective.
Brunström M., Kjeldsen S.E., Kreutz R., Gjesdal K., Narkiewicz K., Burnier M., Oparil S., Mancia G., 2021/08. Hypertension, 78 (2) pp. 555-558. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C79D0D66AF16]
 
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage.
Pisano A., Mallamaci F., D'Arrigo G., Bolignano D., Wuerzner G., Ortiz A., Burnier M., Kanaan N., Sarafidis P., Persu A. et al., 2021/07/31. Nephrology, dialysis, transplantation, 36 (7) pp. 1326–1346. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD36CF663BC5]
 
The unsolved challenge of implementing sustained reductions of sodium intake in patients with chronic kidney disease.
Burnier M., Fouque D., 2021/07/31. Nephrology, dialysis, transplantation, 36 (7) pp. 1148–1151. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_78DF939DB363]
Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?
Burnier Michel, 2021/07. EClinicalMedicine, 37 p. 100983.
[URN][DOI][WoS][serval:BIB_A1DEF6C37D13]
Reply to comment on: Glatz et al. Associations of sodium, potassium and protein intake with blood pressure and hypertension in Switzerland.
Burnier M., 2021/06/07. Swiss medical weekly, 151 pp. w20182. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ADD8F18431E9]
 
Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes - from single pill combinations to monitoring of a nationwide health insurance database.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2021/06. Blood pressure, 30 (3) pp. 143-144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4838EE126EE2]
 
Uromodulin, Salt, and 24-Hour Blood Pressure in the General Population.
Ponte B., Pruijm M., Ackermann D., Olinger E., Youhanna S., Vogt B., Burnier M., Pechere-Bertschi A., Bochud M., Devuyst O., 2021/05/08. Clinical journal of the American Society of Nephrology, 16 (5) pp. 787-789. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA11C0490A01]
 
Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at?
Burnier M., Narkiewicz K., Oparil S., 2021/04. Blood pressure, 30 (2) pp. 79-81. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_190A0860A11D]
 
In memoriam: Jiří Widimský Sr. 1925-2020.
Kreutz R., Cífková R., Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., Mancia G., 2021/04. Blood pressure, 30 (2) pp. 140-142. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E89A759DC917]
 
Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS).
Bandiera C., Dotta-Celio J., Locatelli I., Nobre D., Wuerzner G., Pruijm M., Lamine F., Burnier M., Zanchi A., Schneider M.P., 2021/03/19. JMIR research protocols, 10 (3) pp. e25966. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_063BEE373E97]
Effects of the Dual Endothelin Receptor Antagonist Aprocitentan on Body Weight and Fluid Homeostasis in Healthy Subjects on a High Sodium Diet.
Gueneau de Mussy P., Sidharta P.N., Wuerzner G., Maillard M.P., Guérard N., Iglarz M., Flamion B., Dingemanse J., Burnier M., 2021/03. Clinical pharmacology and therapeutics, 109 (3) pp. 746-753. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1BE20415C0D5]
Editorial: Hypertension in the Elderly.
Coca A., Burnier M., 2021/02/24. Frontiers in cardiovascular medicine, 8 p. 645580. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62D5A707C896]
 
Sodium intake and progression of chronic kidney disease-has the time finally come to do the impossible: a prospective randomized controlled trial?
Burnier M., 2021/02/20. Nephrology, dialysis, transplantation, 36 (3) pp. 381-384. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A568E3D69F2D]
 
In Memoriam: Jiří Widimský Sr. 1925-2020.
Kreutz R., Cífková R., Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., Mancia G., 2021/02/01. Journal of hypertension, 39 (2) pp. 386-388. Peer-reviewed.
[DOI][Pmid][serval:BIB_E8492642F38F]
 
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2021/02. Blood pressure, 30 (1) pp. 1-3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_54ADFB72FD57]
Hip Position Acutely Affects Oxygenation and Perfusion of Kidney Grafts as Measured by Functional Magnetic Resonance Imaging Methods-The Bent Knee Study.
Mani L.Y., Seif M., Nikles F., Tshering Vogel D.W., Diserens G., Martirosian P., Burnier M., Vogt B., Vermathen P., 2021. Frontiers in medicine, 8 p. 697055. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D660D3B6A5E9]
How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice.
Polychronopoulou E., Wuerzner G., Burnier M., 2021. Vascular health and risk management, 17 pp. 1-11. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_688099EFB06D]
 
Sex- and age-specific reference intervals for diagnostic ratios reflecting relative activity of steroidogenic enzymes and pathways in adults
Rousson V., Ackermann D., Ponte B., Pruijm M., Guessous I., d'Uscio C.H., Ehret G., Escher G., Pechère-Bertschi A., Groessl M. et al., 2021. PloS one, 16 (7) pp. e0253975. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0AD742962E49]
Team-Based Care for Improving Hypertension Management: A Pragmatic Randomized Controlled Trial.
Santschi V., Wuerzner G., Pais B., Chiolero A., Schaller P., Cloutier L., Paradis G., Burnier M., 2021. Frontiers in cardiovascular medicine, 8 p. 760662. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_39F359B3F53B]
2020
 
In memoriam: Peter Sleight 1929-2020.
Kreutz R., Kjeldsen S.E., Burnier M., Narkiewicz K., Oparil S., Mancia G., 2020/12. Blood pressure, 29 (6) pp. 382-384. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5416BD8EE9F9]
 
Sodium Intake Is Associated With Renal Resistive Index in an Adult Population-Based Study.
Jaques D.A., Pruijm M., Ackermann D., Vogt B., Guessous I., Burnier M., Pechere-Bertschi A., Bochud M., Ponte B., 2020/12. Hypertension, 76 (6) pp. 1898-1905. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D0FAF0AF120E]
 
Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2020/12. Blood pressure, 29 (6) pp. 341-343. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33997E178EDD]
Water-Soluble Vitamin Levels and Supplementation in Chronic Online Hemodiafiltration Patients.
Schwotzer N., Kanemitsu M., Kissling S., Darioli R., Benghezal M., Rezzi S., Burnier M., Pruijm M., 2020/12. Kidney international reports, 5 (12) pp. 2160-2167. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4497C4C474D8]
 
Clinical Profiles and Factors Associated with a Low Sodium Intake in the Population: An Analysis of the Swiss Survey on Salt.
Burnier M., Paccaud F.M., Bochud M., 2020/11/23. Nutrients, 12 (11) p. 3591. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_10537A268793]
 
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime.
Kreutz R., Kjeldsen S.E., Burnier M., Narkiewicz K., Oparil S., Mancia G., 2020/11. Journal of hypertension, 38 (11) pp. 2144-2145. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0C6D6E48C9F0]
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.
Kielstein J.T., Pontremoli R., Burnier M., 2020/10/31. Current hypertension reports, 22 (12) p. 102. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4AA06E8E5DBB]
 
Blood pressure measurements with the OptiBP smartphone app validated against reference auscultatory measurements.
Schoettker P., Degott J., Hofmann G., Proença M., Bonnier G., Lemkaddem A., Lemay M., Schorer R., Christen U., Knebel J.F. et al., 2020/10/20. Scientific reports, 10 (1) p. 17827. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_62373D69B0AF]
 
The International Society of Hypertension Guidelines 2020 - a new drug treatment recommendation in the wrong direction?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2020/10. Blood pressure, 29 (5) pp. 264-266. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_43AB91647A28]
 
Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?
Burnier M., Kreutz R., Narkiewicz K., Kjeldsen S., Oparil S., Mancia G., 2020/08. Journal of hypertension, 38 (8) pp. 1396-1406. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_83D7BAC5C41F]
 
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
Kreutz R., Algharably EAE, Azizi M., Dobrowolski P., Guzik T., Januszewicz A., Persu A., Prejbisz A., Riemer T.G., Wang J.G. et al., 2020/08/01. Cardiovascular research, 116 (10) pp. 1688-1699. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6DD99ED2180]
 
Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2020/08. Blood pressure, 29 (4) pp. 199-201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE6D990D916F]
 
Screening for hypertension at the hairdresser: a feasibility study in France and Morocco.
Boivin J.M., Risse J., Laurière E., Burnier M., 2020/08. Blood pressure, 29 (4) pp. 202-208. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_636FBC4DD963]
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial.
Zanchi A., Burnier M., Muller M.E., Ghajarzadeh-Wurzner A., Maillard M., Loncle N., Milani B., Dufour N., Bonny O., Pruijm M., 2020/07/07. Journal of the American Heart Association, 9 (13) pp. e016173. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D74B267E8EEE]
 
Increasing potassium intake to prevent kidney damage: a new population strategy?
Burnier M., 2020/07. Kidney international, 98 (1) pp. 59-61. Peer-reviewed.
[DOI][Pmid][serval:BIB_7D26F28B62BF]
 
Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline.
Damianaki K., Lourenco JM, Braconnier P., Ghobril JP, Devuyst O., Burnier M., Lenglet S., Augsburger M., Thomas A., Pruijm M., 2020/07/01. Nephrology, dialysis, transplantation, 35 (7) pp. 1163-1170. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E32F5CB5A041]
 
Antihypertensive drugs and the risk of cancer: a critical review of available evidence and perspective.
Battistoni A., Tocci G., Coluccia R., Burnier M., Ruilope L.M., Volpe M., 2020/06. Journal of hypertension, 38 (6) pp. 1005-1015. Peer-reviewed.
[DOI][Pmid][serval:BIB_B01F29A5D977]
 
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project.
Kreutz R., Kjeldsen S.E., Burnier M., Narkiewicz K., Oparil S., Mancia G., 2020/06. Blood pressure, 29 (3) pp. 135-136. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A1B30AB74547]
 
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.
Pisano A., Bolignano D., Mallamaci F., D'Arrigo G., Halimi J.M., Persu A., Wuerzner G., Sarafidis P., Watschinger B., Burnier M. et al., 2020/05/01. Nephrology, dialysis, transplantation, 35 (5) pp. 878-887. Peer-reviewed.
[DOI][Pmid][serval:BIB_5824E84475AA]
 
Nutraceuticals and blood pressure control: a European Society of Hypertension position document.
Borghi C., Tsioufis K., Agabiti-Rosei E., Burnier M., Cicero AFG, Clement D., Coca A., Desideri G., Grassi G., Lovic D. et al., 2020/05. Journal of hypertension, 38 (5) pp. 799-812. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C2A3FEDD9419]
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.
Mahfoud F., Azizi M., Ewen S., Pathak A., Ukena C., Blankestijn P.J., Böhm M., Burnier M., Chatellier G., Durand Zaleski I. et al., 2020/04/21. European heart journal, 41 (16) pp. 1588-1599. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9E1C2CA5E9A7]
Uranium exposure of the Swiss population based on 24-hour urinary excretion.
Jenny-Burri J., Blanc A., Aubert R., Haldimann M., Zürcher U., Burnier M., Paccaud F., Bochud M., Dudler V., 2020/04/06. Swiss medical weekly, 150 pp. w20207. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C321899C4A30]
Ambulatory Blood Pressure in Relation to Plasma and Urinary Manganese.
Zhang ZY, Carmeli C., Ponte B., Pruijm M., Ackermann D., Ehret G., Guessous I., Petrović D., Pechère-Bertschi A., Vogt B. et al., 2020/04. Hypertension, 75 (4) pp. 1133-1139. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2F14E41018C7]
 
How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers.
Burnier M., Kjeldsen S.E., Narkiewicz K., Oparil S., 2020/04. Blood pressure, 29 (2) pp. 68-69. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BBB2637A58E4]
 
Parathyroid Hormone and Plasma Phosphate Are Predictors of Soluble α-Klotho Levels in Adults of European Descent
Dhayat Nasser A, Pruijm Menno, Ponte Belen, Ackermann Daniel, Leichtle Alexander Benedikt, Devuyst Olivier, Ehret Georg, Guessous Idris, Pechère-Bertschi Antoinette, Pastor Johanne et al., 2020/04/01. The Journal of Clinical Endocrinology and Metabolism, 105 (4) pp. e1135-e1143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29E9B1BA7106]
Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.
Schantl A.E., Verhulst A., Neven E., Behets G.J., D'Haese P.C., Maillard M., Mordasini D., Phan O., Burnier M., Spaggiari D. et al., 2020/02/05. Nature communications, 11 (1) p. 721. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B322953EAB8C]
 
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2020/02. Blood pressure, 29 (1) pp. 1-2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E162ECA5551]
First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH).
Spirk D., Noll S., Burnier M., Rimoldi S., Noll G., Sudano I., 2020. Frontiers in cardiovascular medicine, 7 p. 46. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_89E3E14FB287]
 
How reliable is renal ultrasound to measure renal length and volume in patients with chronic kidney disease compared with magnetic resonance imaging?
Braconnier P., Piskunowicz M., Vakilzadeh N., Müller M.E., Zürcher E., Burnier M., Pruijm M., 2020/01. Acta radiologica, 61 (1) pp. 117-127. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE378390EACB]
Hypertension and Drug Adherence in the Elderly.
Burnier M., Polychronopoulou E., Wuerzner G., 2020. Frontiers in cardiovascular medicine, 7 p. 49. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_25D0B6A98A77]
 
Renal Functional Reserve Is Related to the Nondipping Phenotype and to the Exercise Heart Rate Response in Patients with Essential Hypertension and Preserved Renal Function.
Damianaki K., Burnier M., Dimitriadis K., Tsioufis C., Petras D., 2020. Kidney & blood pressure research, 45 (5) pp. 737-747. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46E1054E38FA]
Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
Burnier M., 2020. Kidney medicine, 2 (3) pp. 231-234. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_75A50801CAE0]
 
Short-term changes in dietary sodium intake influence sweat sodium concentration and muscle sodium content in healthy individuals.
Braconnier P., Milani B., Loncle N., Lourenco J.M., Brito W., Delacoste J., Maillard M., Stuber M., Burnier M., Pruijm M., 2020/01. Journal of hypertension, 38 (1) pp. 159-166. Peer-reviewed.
[DOI][Pmid][serval:BIB_123A2CF57587]
2019
 
Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis.
Burnier M., Lin S., Ruilope L., Bader G., Durg S., Brunel P., 2019/12. Blood pressure, 28 (6) pp. 358-374. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CC7BAF315FEA]
 
Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/12. Blood pressure, 28 (6) pp. 356-357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA9AC29CDB6C]
 
Controversies in the management of patients with arterial hypertension.
Burnier M., 2019/10/25. Kardiologia polska, 77 (10) pp. 902-907. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CBF46E5E8CE8]
 
Sex and Body Mass Index Modify the Association Between Leptin and Sodium Excretion: A Cross-sectional Study in an African Population.
Schwotzer N., Burnier M., Maillard M., Bovet P., Paccaud F., Bochud M., Wuerzner G., 2019/10/16. American journal of hypertension, 32 (11) pp. 1101-1108. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46ED0B752C72]
 
The PARAGON-Heart failure trial - another disappointment for heart failure patients with hypertension and preserved ejection fraction.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/10. Blood pressure, 28 (5) pp. 276-278. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC53B925A78C]
 
Renal Resistive Index Is Associated With Inactive Matrix Gla (γ-Carboxyglutamate) Protein in an Adult Population-Based Study.
Jaques D.A., Pivin E., Pruijm M., Ackermann D., Guessous I., Ehret G., Wei F.F., Staessen J.A., Pechère-Bertschi A., Vermeer C. et al., 2019/09/17. Journal of the American Heart Association, 8 (18) pp. e013558. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD902C423491]
 
Adhésion thérapeutique : le maillon manquant du contrôle tensionnel [Medication adherence : the weakest link in blood pressure control]
Gonzalez A., Pechère-Bertschi A., Burnier M., Schneider M., 2019/09/11. Revue medicale suisse, 15 (662) pp. 1608-1613. Peer-reviewed.
[Pmid][serval:BIB_2E9BA44C022B]
Hypertension de la personne âgée : les nouvelles recommandationsont-elles changé la prise en charge ? [Hypertension in the elderly : have new guidelines changed the management ?]
Polychronopoulou E., Burnier M., Wuerzner G., 2019/09/11. Revue medicale suisse, 15 (662) pp. 1597-1602. Peer-reviewed.
[URN][Pmid][serval:BIB_B82DF0D4232F]
 
Estimated 24-h urinary sodium and sodium-to-potassium ratio are predictors of kidney function decline in a population-based study.
Deriaz D., Guessous I., Vollenweider P., Devuyst O., Burnier M., Bochud M., Ponte B., 2019/09. Journal of hypertension, 37 (9) pp. 1853-1860. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FAA928AD951D]
Redefining diuretics use in hypertension: why select a thiazide-like diuretic?
Burnier M., Bakris G., Williams B., 2019/08. Journal of hypertension, 37 (8) pp. 1574-1586. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E55704A82DF]
 
The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/08. Blood pressure, 28 (4) pp. 215-216. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AB55240E6CED]
 
Cardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial?
Messerli F.H., Burnier M., 2019/06/07. European heart journal, 40 (22) pp. 1787-1789. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E1DE42EC7E02]
 
Exploring a new method for quantitative sodium MRI in the human upper leg with a surface coil and symmetrically arranged reference phantoms.
Milani B., Delacoste J., Burnier M., Pruijm M., 2019/06. Quantitative imaging in medicine and surgery, 9 (6) pp. 985-999. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6692CB130A7C]
 
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/06. Blood pressure, 28 (3) pp. 144-145. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8E741C11DD82]
 
Urinary Sex Steroid and Glucocorticoid Hormones Are Associated With Muscle Mass and Strength in Healthy Adults.
Bochud M., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Escher G., Groessl M., Estoppey Younes S., d'Uscio C.H. et al., 2019/06/01. The Journal of clinical endocrinology and metabolism, 104 (6) pp. 2195-2215. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BD2E259ABECD]
 
Uric acid and hypertension: a focused review and practical recommendations.
De Becker B., Borghi C., Burnier M., van de Borne P., 2019/05. Journal of hypertension, 37 (5) pp. 878-883. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D86C325760F0]
 
Acute hyperglycemia increases renal tissue oxygenation as measured by BOLD-MRI in healthy overweight volunteers.
Vakilzadeh N., Zanchi A., Milani B., Ledoux J.B., Braconnier P., Burnier M., Pruijm M., 2019/04. Diabetes research and clinical practice, 150 pp. 138-143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDDB398D3EE6]
 
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2019/04. Blood pressure, 28 (2) pp. 75-76. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_42703B0EF180]
 
Adherence in Hypertension.
Burnier M., Egan B.M., 2019/03/29. Circulation research, 124 (7) pp. 1124-1140. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5F4B78174CE8]
La peau comme « troisième rein » [The skin as « third kidney »]
Wurzner-Ghajarzadeh A., Braconnier P., Burnier M., Pruijm M., 2019/02/20. Revue medicale suisse, 15 (639) pp. 418-421. Peer-reviewed.
[DOI][Pmid][serval:BIB_F1B7751E0342]
 
New data on antihypertensive drugs and risk of cancer: should we worry?
Burnier M., Narkiewicz K., Kjeldsen S.E., Oparil S., 2019/02. Blood pressure, 28 (1) pp. 1-3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0DD8E728DD67]
 
Should we eat more potassium to better control blood pressure in hypertension?
Burnier M., 2019/02/01. Nephrology, dialysis, transplantation, 34 (2) pp. 184-193. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87D51AAE9D21]
 
Hypertension artérielle [Arterial hypertension : novelties in 2018]
Burnier M., Wuerzner G., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 57-61. Peer-reviewed.
[Pmid][serval:BIB_A315601DCDEF]
Commentary: Statistical Adhockeries Are No Criteria for Legal Decisions-The Case of the Expert Medical Report on the Assessment of Urine Specimens Collected Among Athletes Having Participated to the Vancouver and Sochi Winter Olympic Games.
Burnier M., 2019. Frontiers in sociology, 4 p. 85. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_18A86949C2AE]
 
Image acquisition for intravoxel incoherent motion imaging of kidneys should be triggered at the instant of maximum blood velocity: evidence obtained with simulations and in vivo experiments.
Milani B., Ledoux J.B., Rotzinger D.C., Kanemitsu M., Vallée J.P., Burnier M., Pruijm M., 2019/01. Magnetic resonance in medicine, 81 (1) pp. 583-593. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74D530C8D467]
New Insights on the Role of Sodium in the Physiological Regulation of Blood Pressure and Development of Hypertension.
Polychronopoulou E., Braconnier P., Burnier M., 2019. Frontiers in cardiovascular medicine, 6 p. 136. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_39C873736C00]
Reference intervals for the urinary steroid metabolome: The impact of sex, age, day and night time on human adult steroidogenesis.
Ackermann D., Groessl M., Pruijm M., Ponte B., Escher G., d'Uscio C.H., Guessous I., Ehret G., Pechère-Bertschi A., Martin P.Y. et al., 2019. PloS one, 14 (3) pp. e0214549. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_940B57CFCA8B]
Sodium intake and blood pressure in children with clinical conditions: A systematic review with meta-analysis.
Rios-Leyvraz M., Bloetzer C., Chatelan A., Bochud M., Burnier M., Santschi V., Paradis G., Tabin R., Bovet P., Chiolero A., 2019/01. Journal of clinical hypertension, 21 (1) pp. 118-126. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_06AF00ADA99A]
2018
 
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.
Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D., Coca A., De Simone G., Dominiczak A. et al., 2018/12. Blood pressure, 27 (6) pp. 314-340. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74689DEFB1A4]
 
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/12. Blood pressure, 27 (6) p. 313. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7932EF339650]
 
Conduite à tenir face au syndrome de sécrétion inappropriée d’hormone antidiurétique (SIADH) [Approach to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)]
Martin J., Burnier M., Lu H., 2018/11/21. Revue medicale suisse, 14 (628) pp. 2116-2120. Peer-reviewed.
[Pmid][serval:BIB_E1CCD25F7AC2]
 
Uromodulin and Nephron Mass.
Pivin E., Ponte B., de Seigneux S., Ackermann D., Guessous I., Ehret G., Pechère-Bertschi A., Olinger E., Mohaupt M., Vogt B. et al., 2018/10/08. Clinical journal of the American Society of Nephrology, 13 (10) pp. 1556-1557. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_655A71114C7A]
 
Impact of salt reduction in meals consumed during hemodialysis sessions on interdialytic weight gain and hemodynamic stability.
Colson A., Brinkley A., Braconnier P., Ammor N., Burnier M., Pruijm M., 2018/10. Hemodialysis international. International Symposium on Home Hemodialysis, 22 (4) pp. 501-506. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_27DBF4774CA1]
 
Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/10. Blood pressure, 27 (5) pp. 247-248. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3479764889A0]
 
Hypertension artérielle diastolique isolée : faut-il encore s’en préoccuper ? [Isolated diastolic hypertension : do we still have to care about it ?]
Berney M., Burnier M., Wuerzner G., 2018/09/12. Revue medicale suisse, 14 (618) pp. 1607-1610. Peer-reviewed.
[Pmid][serval:BIB_35C38B8A8D0C]
 
Prise en charge de l’hypertension artérielle : de l’inertie thérapeutique à l’autonomie des patients [Hypertension management : from medical inertia to patient autonomy]
Burnier M., Polychronopoulou E., Wuerzner G., 2018/09/12. Revue medicale suisse, 14 (618) pp. 1602-1605. Peer-reviewed.
[Pmid][serval:BIB_9A390E8BA710]
 
Recommandations américaines sous haute tension [American guidelines under high pressure !]
Pechère-Bertschi A., Wuerzner G., Burnier M., 2018/09/12. Revue medicale suisse, 14 (618) pp. 1594-1597. Peer-reviewed.
[Pmid][serval:BIB_A1684D6C463F]
Functional magnetic resonance imaging of the kidneys: where do we stand? The perspective of the European COST Action PARENCHIMA.
Caroli A., Pruijm M., Burnier M., Selby N.M., 2018/09/01. Nephrology, dialysis, transplantation, 33 (suppl_2) pp. ii1-ii3. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_92D23E27DC2F]
Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review.
Pruijm M., Mendichovszky I.A., Liss P., Van der Niepen P., Textor S.C., Lerman L.O., Krediet CTP, Caroli A., Burnier M., Prasad P.V., 2018/09/01. Nephrology, dialysis, transplantation, 33 (suppl_2) pp. ii22-ii28. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4A2FAC1B8F95]
 
Take a Blood Pressure Pill or Benefit from Renal Denervation?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/09/01. European heart journal, 39 (33) pp. 3010-3012. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_117F4561B3C5]
 
Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/08. Blood pressure, 27 (4) pp. 185-187. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14F0DB260F69]
 
Final Farewell to Alberto Zanchetti MD.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/07/21. European heart journal, 39 (28) pp. 2616-2617. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4875CE090053]
 
Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.
Canivell S., Mohaupt M., Ackermann D., Pruijm M., Guessous I., Ehret G., Escher G., Pechère-Bertschi A., Vogt B., Devuyst O. et al., 2018/07. Journal of endocrinological investigation, 41 (7) pp. 799-808. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7E2DEEA63F9F]
 
Association of 24-Hour Blood Pressure With Urinary Sodium Excretion in Healthy Adults.
van der Stouwe J.G., Carmeli C., Aeschbacher S., Schoen T., Krisai P., Wenger G., Ehret G., Ponte B., Pruijm M., Ackermann D. et al., 2018/06/11. American journal of hypertension, 31 (7) pp. 784-791. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BB4C15D9C9C4]
 
Ambulatory arterial stiffness index and blood pressure response to renal denervation.
Burnier M., 2018/06. Journal of hypertension, 36 (6) pp. 1272-1275. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_54DDBA4BA998]
Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol.
Muller M.E., Pruijm M., Bonny O., Burnier M., Zanchi A., 2018/06. Advances in therapy, 35 (6) pp. 875-885. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5B126CD40DD9]
 
In memoriam: Alberto Zanchetti.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/06. Blood pressure, 27 (3) pp. 123-124. Peer-reviewed.
[DOI][Pmid][serval:BIB_65781B0D11E4]
 
Update on Endothelin Receptor Antagonists in Hypertension.
Burnier M., 2018/05/19. Current hypertension reports, 20 (6) p. 51. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_357E989F109F]
 
Associations of Urinary Caffeine and Caffeine Metabolites With Arterial Stiffness in a Large Population-Based Study.
Ponte B., Pruijm M., Ackermann D., Ehret G., Ansermot N., Staessen J.A., Vogt B., Pechère-Bertschi A., Burnier M., Martin P.Y. et al., 2018/05. Mayo Clinic proceedings, 93 (5) pp. 586-596. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9160FD0FD82A]
 
New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden?
Burnier M., Oparil S., Narkiewicz K., Kjeldsen S.E., 2018/04. Blood pressure, 27 (2) pp. 62-65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9016FB45B954]
Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
Pruijm M., Milani B., Pivin E., Podhajska A., Vogt B., Stuber M., Burnier M., 2018/04. Kidney international, 93 (4) pp. 932-940. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_13E0FF52CCA9]
 
Hypertension Guidelines.
Burnier M., 2018/03/14. European heart journal, 39 (11) pp. 908-910. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE3C6EA1C27B]
 
Dialyse et réduction des coûts de la santé : des solutions éthiquement acceptables ? []
Burnier M., Martin P.Y., 2018/02/21. Revue medicale suisse, 14 (595) pp. 403-404. Peer-reviewed.
[Pmid][serval:BIB_D261396F9D47]
 
Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.
Persu A., Gordin D., Jacobs L., Thijs L., Bots M.L., Spiering W., Miroslawska A., Spaak J., Rosa J., de Jong M.R. et al., 2018/02. Journal of hypertension, 36 (2) pp. 221-229. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A367006F32B]
 
Challenges in oscillometric blood pressure measurement in atrial fibrillation: looking for practical solutions.
Narkiewicz K., Kjeldsen S.E., Burnier M., Oparil S., 2018/02. Blood pressure, 27 (1) pp. 1-2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C236D634A926]
 
Urinary Cadmium Excretion Is Associated With Increased Synthesis of Cortico- and Sex Steroids in a Population Study.
Bochud M., Jenny-Burri J., Pruijm M., Ponte B., Guessous I., Ehret G., Petrovic D., Dudler V., Haldimann M., Escher G. et al., 2018/02/01. The Journal of clinical endocrinology and metabolism, 103 (2) pp. 748-758. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D1CB298A7F9]
 
Dyspnée et hypertension artérielle []
Burnier M., 2018/01/24. Revue medicale suisse, 14 (591) pp. 201-202. Peer-reviewed.
[Pmid][serval:BIB_2673A64776DC]
 
Prise en charge de l’hypertension artérielle [Blood pressure management : what's new in 2017 ?]
Burnier M., Wuerzner G., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 46-48. Peer-reviewed.
[Pmid][serval:BIB_6B549EDD090B]
Blood Pressure and Renal Responses to Orthostatic Stress Before and After Radiofrequency Renal Denervation in Patients with Resistant Hypertension.
Vuignier Y., Grouzmann E., Muller O., Vakilzadeh N., Faouzi M., Maillard M.P., Qanadli S.D., Burnier M., Wuerzner G., 2018. Frontiers in cardiovascular medicine, 5 p. 42. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9B71C90D5E6F]
Effect of Home Blood Pressure Monitoring on Patient's Awareness and Goal Attainment Under Antihypertensive Therapy: The Factors Influencing Results in Anti-HypertenSive Treatment (FIRST) Study.
Spirk D., Noll S., Burnier M., Rimoldi S., Noll G., Sudano I., 2018. Kidney & blood pressure research, 43 (3) pp. 979-986. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BBBF0FB92D1B]
Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction.
Wei F.F., Trenson S., Monney P., Yang W.Y., Pruijm M., Zhang Z.Y., Bouatou Y., Huang Q.F., Ponte B., Martin P.Y. et al., 2018. PloS one, 13 (3) pp. e0193967. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB5AA46EEA43]
Is There a Threshold for Medication Adherence? Lessons Learnt From Electronic Monitoring of Drug Adherence.
Burnier M., 2018. Frontiers in pharmacology, 9 p. 1540. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_345ABEACC3CD]
 
Prevalence of Hypertensive Phenotypes After Preeclampsia: A Prospective Cohort Study.
Ditisheim A., Wuerzner G., Ponte B., Vial Y., Irion O., Burnier M., Boulvain M., Pechère-Bertschi A., 2018/01. Hypertension, 71 (1) pp. 103-109. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC9EEF1BC857]
 
Should renal color Doppler ultrasonography be a routine test in newly diagnosed hypertensive patient?
Tsioufis C., Andrikou I., Pruijm M., Ponte B., Sarafidis P., Koureas A., Tousoulis D., Agabiti-Rosei E., Mancia G., Burnier M., 2018/01. Journal of hypertension, 36 (1) pp. 16-22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C08B928143C1]
Symptoms and quality of life from patients undergoing hemodialysis in Switzerland
Delmas Philippe, Cohen Christine, Loiselle Marie-Chantal, Antonini Matteo, Pasquier Jerome, Burnier Michel, 2018. Clinical Nursing Studies, 6 (2) pp. 63-72.
[URN][DOI][serval:BIB_2D5DA2F6225A]
2017
 
Optimizing hypertension management in renal transplantation: a call to action.
Halimi J.M., Persu A., Sarafidis P.A., Burnier M., Abramowicz D., Sautenet B., Oberbauer R., Mallamaci F., London G., Rossignol P. et al., 2017/12/01. Nephrology, dialysis, transplantation, 32 (12) pp. 1959-1962. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_25A6F902FB25]
 
Reduction of cortical oxygenation in chronic kidney disease: evidence obtained with a new analysis method of blood oxygenation level-dependent magnetic resonance imaging.
Milani B., Ansaloni A., Sousa-Guimaraes S., Vakilzadeh N., Piskunowicz M., Vogt B., Stuber M., Burnier M., Pruijm M., 2017/12/01. Nephrology, dialysis, transplantation, 32 (12) pp. 2097-2105. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3569F6D161D1]
 
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?
Burnier M., Narkiewicz K., Kjeldsen S.E., Oparil S., 2017/12. Blood pressure, 26 (6) pp. 319-320. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E2EEC9E3B375]
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
Mahfoud F., Schmieder R.E., Azizi M., Pathak A., Sievert H., Tsioufis C., Zeller T., Bertog S., Blankestijn P.J., Böhm M. et al., 2017/11/21. European heart journal, 38 (44) pp. 3272-3281. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7E690E043D01]
 
Drug adherence in hypertension.
Burnier M., 2017/11. Pharmacological research, 125 (Pt B) pp. 142-149. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6273ABD113E0]
 
Reply to Chalmers J. Guidelines under fire again!.
Messerli F.H., Hofstetter L., Agabiti-Rosei E., Burnier M., Elliott W.J., Franklin S.S., Grodzicki T., Kario K., Kjeldsen S.E., Kostis J.B. et al., 2017/11. Journal of hypertension, 35 (11) pp. 2327-2328. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8BE300D375A9]
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring
Forni Ogna Valentina, Bassi Isabelle, Menetrey Isabelle, Muller Olivier, Tousset Eric, Fontana Pierre, Eeckhout Eric, Eap Chin B., Vrijens Bernard, Burnier Michel et al., 2017/10/25. Frontiers in Pharmacology, 8 pp. NA. Peer-reviewed.
[URN][DOI][WoS][serval:BIB_6CD4716A9D7A]
 
Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.
Pruijm M., Lu Y., Megdiche F., Piskunowicz M., Milani B., Stuber M., Bachtler M., Vogt B., Burnier M., Pasch A., 2017/10. Journal of hypertension, 35 (10) pp. 2044-2052. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F52B208EC18F]
 
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/10. Blood pressure, 26 (5) pp. 257-258. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4121ED08D0F3]
 
Comment initier un traitementantihypertenseur ? De l’évidenceà la personnalisation [How to start an antihypertensive treatment: from evidence to personalized choice]
Forni Ogna V., Braconnier P., Wuerzner A., Burnier M., Wuerzner G., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1558-1564. Peer-reviewed.
[Pmid][serval:BIB_5560E941B629]
 
Femmes médecins, anges gardiens ? []
Pechère-Bertschi A., Wuerzner G., Burnier M., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1555-1556. Peer-reviewed.
[Pmid][serval:BIB_D444799A92D8]
 
Hypertension et dysplasie fibromusculaire :au-delà des artères rénales [Fibromuscular dysplasia and hypertension : beyond renal arteries]
Wuerzner G., Krieger C., Bouchardy J., Toubiana L., Delmotte P., Van der Niepen P., Déglise S., Qanadli S., Burnier M., Mazzolai L. et al., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1580-1583. Peer-reviewed.
[Pmid][serval:BIB_7D763B42C3AD]
Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury.
Demirjian S., Ailawadi G., Polinsky M., Bitran D., Silberman S., Shernan S.K., Burnier M., Hamilton M., Squiers E., Erlich S. et al., 2017/09. Kidney international reports, 2 (5) pp. 836-843. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6ECEC80232BA]
 
Seasonality of sodium and potassium consumption in Switzerland. Data from three cross-sectional, population-based studies.
Marti-Soler H., Pommier C., Bochud M., Guessous I., Ponte B., Pruijm M., Ackermann D., Forni Ogna V., Paccaud F., Burnier M. et al., 2017/09. Nutrition, metabolism, and cardiovascular diseases, 27 (9) pp. 792-798. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4508E6FF9407]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University